Abstract
Pruritus, secondary to chronic renal failure, can be an extremely distressing symptom. A 15-year-old girl, in end-stage renal disease, presented with pruritus that did not improve on starting peritoneal dialysis. Despite normalising the calcium, phosphate and parathyroid levels, pruritus worsened and showed no response to antihistamines. She was commenced on ondansetron and showed dramatic improvement. Severe uraemic pruritus is rare, but distressing in children and can improve with ondansetron.
References
Mettang T, Pauli-Magnus C, Alscher DM (2002) Uraemic pruritus—new perspectives and insights from recent trials. Nephrol Dial Transplant 17:558–563
Mettang T, Fischer FP, Kuhlmann U (1996) Urämischer pruritus—pathophysiologische and therapeutische konzepte. Dtsch Med Wochenschr 121:1025–1031
Pauli-Magnus C, Mikus G, Alscher DM, Kirschner T, Nagel W, Gugeler N, Risler T, Berger ED, Kuhlmann U, Mettang T (2000) Naltrexone does not relieve uraemic pruritus: results of a randomised, placebo-controlled crossover-study. J Am Soc Nephrol 11:514–519
Schwab M, Mikus G, Mettang T, Pauli-Magnus C, Kuhlmann U and Arbeitsgemeinschaft für Pädiatrische Nephrologie (1999) Urämischer Pruritus im Kindes- und Jugendalter. Monatsschr Kinderheilkd 147:232
Massry S, Popovzer MM, Coburn JM, Mokoff DL, Maxwell MH, Kleeman CR (1968) Intractable pruritus as a manifestation of secondary hyperparathyroidism in uraemia. N Engl J Med 279:697–700
Stahle-Backdahl M, Hagermark O, Lins LE, Torring O, Hillinges M, Johansson O (1989) Experimental and immunohistochemical studies on the possible role of parathyroid hormone in uraemic pruritus. J Intern Med 225:411–415
Blachley JD, Blankenship DM, Menter A, Parker TF III, Knochel JP (1985) Uraemic pruritus: skin divalent ion content and response to ultraviolet phototherapy. Am J Kidney Dis 5:237–241
Sakata-Kaneko S, Wakatsuki Y, Matsunaga Y, Usui T, Kita T (2000) Altered Th1/Th2 commitment in human CD4 T cells with ageing. Clin Exp Immunol 120:276–310
McHugh SM, Rifkin IR, Deighton J, Wilson AB, Lachmann PJ, Lockwood CM, Ewan PW (1995) The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol 99:160–167
Suthanthiran M, Strom TB (1994) Renal transplantation. N Engl J Med 331:365–376
Davis MP, Frandsen JL, Walsh D, Andersen S, Taylor S (2003) Mirtazapine for pruritus. J Pain Symptom Manage 25:188–191
Schworer H, Hartmann H, Ramadori G (1995) Relief of cholestatic pruritus by a novel class of drugs: 5-HT3 receptor antagonists: Effectiveness of ondansetron. Pain 61:33–37
Balaskas EV, Bamihas GI, Karamouzis M, Voyiatzis G, Tourkantonis A (1998) Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients. Nephron 78:395–402
Ashmore SD, Jones CH, Newstead CG, Daly MJ, Chrystyn H (2000) Ondansetron therapy for uremic pruritus in haemodialysis patients. Am J Kidney Dis 35:827–831
Murphy M, Reaich D, Pai P, Finn P, Carmicheal AJ (2003) A randomised, placebo-controlled, double-blind trial of ondansetron in renal itch. Br J Dermatol 148:314–317
Schworer H, Ramadori G (1993) Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists. Clin Invest 71:659–662
Silverberg NB, Singh A, Laude TA (2001) Cutaneous manifestations of chronic renal failure in children of color. Pediatr Dermatol 18:199–204
Altmeyer P, Kachel HG, Schafer G, Fabinder W (1986) Normalisierung der Urämischen Hautveränderungen nach Nierentransplantation. Hautarzt 37:217–221
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Deshpande, P.V. Ondansetron for paediatric uraemic pruritus: a case report. Pediatr Nephrol 19, 694–696 (2004). https://doi.org/10.1007/s00467-004-1471-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-004-1471-7